Intrinsic Value of S&P & Nasdaq Contact Us

ProSomnus, Inc. OSA NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
34/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

ProSomnus, Inc. (OSA) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 33/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
34/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — OSA

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.49
Book Value / Share$0.00
Revenue / Share$1.71
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2020 $-0.38 $8.29M $-6.17M -74.5%
2021 $-1.51 $14.07M $-5.98M -42.5%
2022 $0.33 $19.39M $3.3M 17%
2023 $-1.49 $27.65M $-24.1M -87.1%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message